CYP19A1 and neurodegenerative disease: Using RT-PCR and immunohistochemistry, we compared the expression of aromatase mRNA and protein in postmortem hippocampal tissue of individuals diagnosed with AD and of individuals that did not have any neurodegenerative disease.